JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

FLASH臨床試験の品質保証と報告: FEATHER試験の経験

  • 0Center for Proton Therapy, Paul Scherrer Institut, Villigen PSI, Switzerland.
Medical Physics +

|

2025年9月4日

PubMedで要約を見る

まとめ

この要約は機械生成です。

関連する概念動画

Clinical Trials: Overview 01:11

3.4K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials 01:16

7.8K

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Quality Assurance 01:19

198

Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...

Preclinical Development: Overview 01:28

4.8K

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Pharmacovigilance 01:19

983

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Standards of Care II 01:19

725

Nurses bear specific legal responsibilities under several federal statutes, including:

• The Health Insurance Portability and Accountability Act (HIPAA) which was enacted on August 21, 1996.
• The Health Information Technology for Economic and Clinical Health Act (HITECH) which was enacted on February 17, 2009.
• The Patient Self-Determination Act (PSDA) which was enacted on December 1, 1991.

These laws are pivotal in safeguarding patient rights and privacy and...